24
Participants
Start Date
February 28, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
March 30, 2028
BW-20805
SC administrations of BW-20805 600 mg on Day1 to Day673
BW-20805
SC administrations of BW-20805 300 mg every 24 weeks on Day1 to Day169;Day337 to Day673
BW-20805
SC administrations of BW-20805 300 mg every 12 weeks on Day 1 to Day 589
RECRUITING
Charité - Universitätsmedizin Berlin, Berlin
RECRUITING
Penn State Milton S. Hershey MC - Penn State, Hershey
RECRUITING
Institute for Asthma and Allergy - Wheaton, Silver Spring
RECRUITING
Inova Clinical Trials and Research Center, Falls Church
RECRUITING
Duke University Medicine Center, Durham
NOT_YET_RECRUITING
Azienda Ospedale - Universita di Padova, Padua
RECRUITING
Hospital Universitario Virgen del Rocío, Seville
RECRUITING
Azienda Ospedaliero-Universitaria Careggi, Florence
RECRUITING
Universitätsmedizin der Johannes Gutenberg, Mainz
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco, Catania
RECRUITING
Peking Union Medical College Hospital, Beijing
NOT_YET_RECRUITING
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan
RECRUITING
Yantai Yuhuangding Hospital, Yantai
RECRUITING
West China Hospital, Sichuan University, Chengdu
RECRUITING
First Affiliated Hospital of Kunming Medical University, Kunming
RECRUITING
The First Hospital of Lanzhou University, Lanzhou
NOT_YET_RECRUITING
SP ZOZ Szpital Uniwersytecki w Krakowie, Krakow
Shanghai Argo Biopharmaceutical Co., Ltd.
INDUSTRY